Zevra Therapeutics, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 13 13 29 10 27 24
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% 3.5% 115.6% -63.5% 162.6% -14.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 77.1% 90.2% 92.8% 96.7% 85.6% 68.6%
EBIT (mln) -5 -5 -16 -23 -37 -33 -56 -20 -5 8 -25 -50 -87
EBIT Δ r/r 0.0% -11.6% 248.5% 38.7% 64.3% -11.0% 67.5% -63.6% -76.5% -261.7% -421.4% 99.7% 75.4%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -158.4% -36.0% 27.0% -237.5% -180.6% -368.5%
Koszty finansowe (mln) 0 0 3 3 7 7 7 7 7 0 0 2 -7
EBITDA (mln) -5 -5 -16 -23 -34 -33 -54 -20 -5 8 -24 -49 -87
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -156.0% -35.3% 27.8% -230.3% -177.0% -368.5%
Podatek (mln) 0 -0 -0 0 -0 -0 -0 -0 -0 0 -1 0 -15
Zysk Netto (mln) -0 -5 -24 -55 -17 -43 -56 -25 -13 -9 -42 -46 -106
Zysk netto Δ r/r 0.0% 7321.6% 367.9% 123.5% -69.8% 162.7% 30.1% -56.6% -48.0% -33.0% 385.6% 10.8% 129.1%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -191.0% -96.0% -29.9% -397.2% -167.7% -446.9%
EPS -0.47 -10.69 -31.79 -118.69 -18.1 -47.37 -50.39 -13.23 -3.21 -0.29 -1.2 -1.3 -2.28
EPS (rozwodnione) -0.47 -10.69 -31.79 -118.69 -18.1 -47.37 -50.39 -13.23 -3.21 -0.29 -1.2 -1.3 -2.28
Ilośc akcji (mln) 0 0 1 0 1 1 1 2 4 30 34 35 46
Ważona ilośc akcji (mln) 0 0 1 0 1 1 1 2 4 30 34 35 46
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD